Archive for August, 2008
Addressing Clinical Trial Recruitment and Retention Issues Imposed by HIPAA Step by Step (first of a series)
Recent reports indicate that the Health Insurance Portability and Accountability Act (HIPAA) that went into effect in 2003 has adversely affected clinical trial conduct by (a) increasing researchers’ administrative burden; (b) increasing overall trial conduct costs; (c) delaying initial project approval; (d) hampering medical record and registry research, and most critical; (e) impeding clinical trial recruiting [...]
22Aug2008 | admin | 0 comments | ContinuedPrevent Lost To Follow-Up With OmniTrace’s Patient Locator Service
Patient Locator
Our OmniTrace patient locator division has located well over five thousand patients who were at one point considered lost to follow-up.
Finding missing people is all we do (well almost). We have located tens of thousands of people including: clinical trial patients, lost friends, military personnel, lost loves, classmates, debtors, dead beat parents, missing heirs, lost family members [...]
Impact Of HIPAA On Clinical Trial Conduct
Clinical Trial Conduct
Assuring full compliance of guidelines mandated by governing authorities is critical to conducting successful clinical trial research and to subsequent product approval. The federal government’s medical privacy rule, the Health Insurance Portability and Accountability Act (HIPAA), that went into effect in 2003 is such a mandate. It has greatly impacted the conduct of [...]
Find Patient | Find Patient Fast - Improve Clinical Trial Retention
Patient Find
Patient Recruiters, Principal Investigators and Study Coordinators can greatly improve clinical trial retention and reduce patients lost to follow-up by simply obtaining more contact information when the patient is first recruited into a study. Detailed contact information will allow a search company, such as OmniTrace, many more avenues to find a patient in the event the patient becomes [...]
Efficiency of Clinical Trials Require Effective Recruitment, Retention and Return
Efficiency of Clinical Trials
Conducting clinical trials is becoming increasingly arduous for drug manufactures due to several factors including: (a) heightened food and drug (FDA) regulatory scrutiny based on recent safety concerns; (b) inefficiencies and/or unclear guidance imposed by Health Insurance Portability and Accountability Act (HIPAA) guidelines in the research, design, enrollment and follow-up processes; (c) [...]
